- Your Challenges
- Offerings
- News & Events
- Knowledge Center
- About Us
- Diagnostics
innovations for managing the most challenging diseases and molecular laboratory demands
DISCOVER
Molecular test offerings for Covid-19
Qualitative assay options for use under the FDA Emergency Use Authorization (EUA) to support efforts in COVID-19 testing with automated, high throughput systems that meet different lab needs.
M2000 Realtime System and Assays
Automation system with a comprehensive infectious disease assay menu along with LDT capability and primary tube utilization delivers operational efficiency, reliability and confidence in results.
ALINITY M SYSTEM AND ASSAYS
Fully integrated, automated, high throughput molecular diagnostics analyzer with high quality assays that deliver the next level of flexibility and efficiency to your lab.
UROVYSION BLADDER CANCER KIT
The only urine-based molecular test approved by the FDA to aid in bladder cancer surveillance and assist with diagnosis.
You are about to exit the Abbott family of websites for a 3rd party website
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Do you wish to continue and exit this website?
Yes NoYou are about to enter an Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.